0001656695-17-000001.txt : 20170809 0001656695-17-000001.hdr.sgml : 20170809 20170809110909 ACCESSION NUMBER: 0001656695-17-000001 CONFORMED SUBMISSION TYPE: D PUBLIC DOCUMENT COUNT: 1 ITEM INFORMATION: 06b FILED AS OF DATE: 20170809 DATE AS OF CHANGE: 20170809 EFFECTIVENESS DATE: 20170809 FILER: COMPANY DATA: COMPANY CONFORMED NAME: Resonant Therapeutics, Inc. CENTRAL INDEX KEY: 0001656695 IRS NUMBER: 465197601 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: D SEC ACT: 1933 Act SEC FILE NUMBER: 021-292422 FILM NUMBER: 171016850 BUSINESS ADDRESS: STREET 1: 1349B EAST VALLEY ROAD CITY: SANTA BARBARA STATE: CA ZIP: 93108 BUSINESS PHONE: 925.389.8539 MAIL ADDRESS: STREET 1: 1349B EAST VALLEY ROAD CITY: SANTA BARBARA STATE: CA ZIP: 93108 D 1 primary_doc.xml X0708 D LIVE 0001656695 Resonant Therapeutics, Inc. 1349B EAST VALLEY ROAD SANTA BARBARA CA CALIFORNIA 93108 925.389.8539 DELAWARE None None Corporation true 2014 John K. Westwick 1349 B East Valley Road Santa Barbara CA CALIFORNIA 93108 Executive Officer Director CEO & President Dan Watkins One Greenway Plaza, Suite 930 Houston TX TEXAS 77046 Executive Officer Director Secretary Biotechnology Decline to Disclose 06b false 2017-08-03 false true false 25000 2647326 1390230 1257096 false 3 0 0 0 false Resonant Therapeutics, Inc. /S/ JOHN K. WESTWICK John K. Westwick CEO 2017-08-04